559 related articles for article (PubMed ID: 17339839)
1. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
2. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
[TBL] [Abstract][Full Text] [Related]
4. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
9. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands.
Cabilla JP; Ronchetti SA; Nudler SI; Miler EA; Quinteros FA; Duvilanski BH
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E731-7. PubMed ID: 19141686
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR; Nakanishi H; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
[TBL] [Abstract][Full Text] [Related]
12. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
13. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells.
Browner NC; Dey NB; Bloch KD; Lincoln TM
J Biol Chem; 2004 Nov; 279(45):46631-6. PubMed ID: 15337747
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
17. Intravenous and gastric cerium dioxide nanoparticle exposure disrupts microvascular smooth muscle signaling.
Minarchick VC; Stapleton PA; Fix NR; Leonard SS; Sabolsky EM; Nurkiewicz TR
Toxicol Sci; 2015 Mar; 144(1):77-89. PubMed ID: 25481005
[TBL] [Abstract][Full Text] [Related]
18. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
19. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
